Literature DB >> 2727617

Plasma fibrinogen in unstable coronary artery disease.

E Swahn1, H von Schenck, L Wallentin.   

Abstract

The fibrinogen and orosomucoid levels in plasma were studied in 249 patients within 24 h after admission to the coronary care unit because of suspected unstable coronary artery disease (CAD), i.e. unstable angina pectoris or non-Q-wave myocardial infarction (MI). Of these patients, 127 were considered to have unstable CAD either because of symptoms and signs of coronary insufficiency at a pre-discharge exercise test (n = 66) or because of the development of a probable or definite non-Q-wave MI (n = 61). The other chest pain patients without objective signs of myocardial ischaemia constituted the control group. A diagnosis of unstable CAD, and the occurrence of obesity or current smoking contributed independently to elevated fibrinogen and orosomucoid levels. In patients with non-Q-wave MI both the fibrinogen and orosomucoid levels were high regardless of obesity and smoking, indicating myocardial necrosis as a prominent cause for the elevation of these acute phase reactants. Obesity and smoking seemed to influence the metabolism of fibrinogen and orosomucoid and change their basal level and/or exaggerate their response to inflammatory stimuli. The increased fibrinogen level in unstable CAD might reflect a hypercoagulable state that contributes toward a progression of coronary lesions.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2727617     DOI: 10.3109/00365518909089077

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  2 in total

Review 1.  Epidemiology of cardiovascular disease in type 2 diabetes: the Indian scenario.

Authors:  Viswanathan Mohan; Janarthanan Vijay Venkatraman; Rajendra Pradeepa
Journal:  J Diabetes Sci Technol       Date:  2010-01-01

2.  Serum sialic acid concentration and cardiovascular mortality.

Authors:  G Lindberg; G A Eklund; B Gullberg; L Råstam
Journal:  BMJ       Date:  1991-01-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.